A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT01725256 · TERMINATED
Trial details
- NCT number
- NCT01725256
- Sponsor
- Aires Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.